PCI in Advanced Triple Negative Breast Cancer Patients Who Response to 1st Line Chemotherapy
Clinical trial NCT02448576 · UNKNOWN
Trial details
- NCT number
- NCT02448576
- Sponsor
- wang shusen
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-01
- Primary completion
- 2025-08-01
- Enrollment
- 326
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.